Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Dupilumab for Asthma
Recruiting3 awardsPhase 4
Ann Arbor, Michigan
This trial is investigating whether the study drug, dupilumab, can improve the health of participants lungs, boost immune response, as well as improve quality of life for people with severe asthma.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.